Beam Therapeutics Downside Deviation
| BEAM Stock | | | USD 32.32 0.85 2.70% |
Downside Deviation (or DD) is measured by target semi-deviation (the square root of target semi-variance) and is termed downside risk. It is expressed in percentages and therefore allows for rankings in the same way as standard deviation. An intuitive way to view the downside risk is the annualized standard deviation of returns below the target. Below is Beam Therapeutics's current Downside Deviation with peer comparisons and related risk metrics.
Current Downside Deviation Value
The current Downside Deviation of 4.28 places Beam Therapeutics at elevated price variability. This places Beam Therapeutics toward the higher end of the volatility range for Biotechnology.
Downside Deviation | = | SQRT(DV) |
| = | 4.28 | |
Downside Deviation Peers Comparison
The peer group averages 4.46 for Downside Deviation, with Beam Therapeutics at 4.28 falling below that level. Readings span 2.89 (89bio Inc) to 7.6 (Immunitybio). Beam Therapeutics has exhibited less price dispersion than the peer average over the measured period.
Downside Deviation Relative To Other Indicators
The chart below plots Downside Deviation against Maximum Drawdown for Beam Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Downside Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Beam Therapeutics shows nearly
5.62 of Maximum Drawdown per unit of Downside Deviation (
4.28 versus
24.09 ). This indicates Maximum Drawdown substantially exceeds Downside Deviation for Beam Therapeutics.
Methodology, Assumptions & Data Sources
Beam Therapeutics' Downside Deviation currently stands at 4.28. Beam Therapeutics' Downside Deviation is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. The underlying data comes from exchange-reported daily closes with corporate action adjustments applied where relevant. Beam Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Results are based on historical returns and do not predict future performance. This indicator is provided for informational purposes.
Other Technical Indicators